Kathleen Davy

BioCina has both strong core values to the business and a clear vision for the future. Pharmaceutical manufacturing is core to bringing medicines and application of new technologies to patients. BioCina’s 5-year vision for growth will only improve the development pathway to the clinic. Further coupled with the rapidly expanding biotechnology landscape here in Australia, across new modalities and applications such as mRNA and Cell & Gene Therapies, it is very exciting to develop and innovate.